4.5 Article

Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor

Jonathan E. Wilson et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Article Chemistry, Medicinal

Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases

Michael R. Michaelides et al.

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Article Biochemistry & Molecular Biology

Super-Enhancers in the Control of Cell Identity and Disease

Denes Hnisz et al.

Review Biochemistry & Molecular Biology

Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition

Feng Wang et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2013)

Review Genetics & Heredity

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

Michael Haberland et al.

NATURE REVIEWS GENETICS (2009)

Article Pharmacology & Pharmacy

CBP and p300: HATs for different occasions

E Kalkhoven

BIOCHEMICAL PHARMACOLOGY (2004)

Article Biochemistry & Molecular Biology

p300/CBP and cancer

NG Iyer et al.

ONCOGENE (2004)

Review Biochemistry & Molecular Biology

CREB-binding protein and p300 in transcriptional regulation

N Vo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)